Aurobindo Pharma Ltd Share Price History : Returns Comparison, Growth Analysis

Home

Insights

History

Aurobindo Pharma Ltd Share Price History

₹ 5.1 Cr

Volume transacted

34.8 K

stocks traded

Last Updated time: 03 Oct 15:30 PM

Aurobindo Pharma Ltd

BSE

03 Oct, 2024

1457.819.3 (1.3%)

Prev Close

1438.55

Open Price

1438.55

Bid Price (QTY)

0.0 (0)

Offer Price (QTY)

0.0 (0)

Volume

34766

Today's High / Low

1463.0 / 1425.1

52 WK High / Low

1592.6 / 834.9

NSE

03 Oct, 2024

1458.620.3 (1.4%)

Prev Close

1438.3

Open Price

1438.3

Bid Price (QTY)

1458.6 (240)

Offer Price (QTY)

0.0 (0)

Volume

2603178

Today's High / Low

1463.3 / 1425.0

52 WK High / Low

1592.0 / 834.7

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

To make informed investment decisions, regularly checking Aurobindo Pharma Ltd share price can be a beneficial practice. *All values are in Rupees.

Last Ten Days Share Price

Date	Price	Day Open	Day High	Day Low

03 Oct 2024	1457.8	1438.55	1463	1425.05
01 Oct 2024	1438.55	1460	1462.25	1406.85
30 Sep 2024	1460.9	1500	1516.65	1443.5
27 Sep 2024	1509.75	1500.1	1520.45	1489.5
26 Sep 2024	1515.45	1534.85	1534.85	1494.25
25 Sep 2024	1527.95	1509.95	1531.7	1499
24 Sep 2024	1502.75	1481.5	1507.7	1471.15
23 Sep 2024	1480.1	1496.85	1509.5	1471.6
20 Sep 2024	1496.85	1539.35	1539.35	1483.9
19 Sep 2024	1527.35	1550	1560.3	1511.55

Date	Price
03 Oct 2024	1457.8
01 Oct 2024	1438.55
30 Sep 2024	1460.9
27 Sep 2024	1509.75
26 Sep 2024	1515.45
25 Sep 2024	1527.95
24 Sep 2024	1502.75
23 Sep 2024	1480.1
20 Sep 2024	1496.85
19 Sep 2024	1527.35

Returns Comparison

10Y

Returns Comparison Table

Entity	1W	1M	3M	6M	1Y	3Y	5Y	10Y

Cipla Ltd	1.6	1.0	12.5	11.2	40.7	68.6	303.3	166.9
Dr Reddys Laboratories Ltd	1.4	-1.8	6.2	7.9	23.6	36.2	150.8	110.8
Torrent Pharmaceuticals Ltd	-3.0	-1.7	21.2	25.8	79.2	118.8	316.5	663.8
Sun Pharmaceuticals Industries Ltd	2.7	5.7	26.5	17.7	68.1	132.3	396.5	123.1
Aurobindo Pharma Ltd	-4.3	-7.4	18.7	29.3	58.4	100.6	149.4	197.9
Divis Laboratories Ltd	1.0	7.7	17.9	52.0	45.7	12.3	234.3	506.7

Entity	1W
Cipla Ltd	1.6
Dr Reddys Laboratories Ltd	1.4
Torrent Pharmaceuticals Ltd	-3.0
Sun Pharmaceuticals Industries Ltd	2.7
Aurobindo Pharma Ltd	-4.3
Divis Laboratories Ltd	1.0

Last updated time: 03 Oct 15:30 PM

Growth Parameters

Parameter	2017	2018	2019	2020	2021	2022	2023	2024

Sales	15090	16500	19564	23099	24775	23455	24855	29002
Sales YoY Gr.	-	9.3%	18.6%	18.1%	7.3%	-5.3%	6.0%	16.7%
Adj EPS	38.88	41.35	40.36	48.54	91.04	45.18	32.9	54.09
YoY Gr.	-	6.3%	-2.4%	20.3%	87.6%	-50.4%	-27.2%	64.4%
Adj Net Profit	2301	2423	2365	2844	5334	2647	1928	3169
BVPS	159.96	199.36	237.08	287.16	374.29	419.46	458.1	509.35

Parameter	2017
Sales	15090
Sales YoY Gr.	-
Adj EPS	38.88
YoY Gr.	-
Adj Net Profit	2301
BVPS	159.96

Key Financial Parameters

Parameter	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

Return on Capital Emp. %	27.13	27.3	24.89	22.66	17.91	18.51	18.29	12.41	9.18	13.51
Op. Profit Mgn %	21.68	24.32	23.56	23.5	20.56	21.71	22.84	19.39	16.08	21.35
Net Profit Mgn %	12.8	14.5	15.25	14.68	12.09	12.31	13.76	11.29	7.76	10.93
Debt to Equity %	0.92	0.76	0.5	0.39	0.46	0.42	0.29	0.18	0.16	0.21

Parameter	2015
Return on Capital Emp. %	27.13
Op. Profit Mgn %	21.68
Net Profit Mgn %	12.8
Debt to Equity %	0.92

Latest Shareholding

No data available

Promoters Holdings Over Time

No data available

About Aurobindo Pharma Ltd

Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
Mr. P.
V.
Ramaprasad Reddy, Mr. K.
Nityananda Reddy and a small, highly committed group of professionals founded it.

Check out other companies share price history

Sun Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...

Divis Laboratories Ltd

Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...

Cipla Ltd

The Company is in the business of manufacturing, developing, and marketing wide ...

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...

Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company...

Popular Search

Aurobindo Pharma Ltd dividend

Aurobindo Pharma Ltd pe ratio

Aurobindo Pharma Ltd market cap

Aurobindo Pharma Ltd option chain

Aurobindo Pharma Ltd financials

Sun Pharmaceuticals Industries Ltd share price history

Divis Laboratories Ltd share price history

Cipla Ltd share price history

Torrent Pharmaceuticals Ltd share price history

Dr Reddys Laboratories Ltd share price history

Zydus Lifesciences Ltd share price history

Mankind Pharma Ltd share price history

Lupin Ltd share price history

Alkem Laboratories Ltd share price history

Abbott India Ltd share price history

FAQs for of Aurobindo Pharma Ltd

What factors influence the share price of Aurobindo Pharma Ltd over time?

The share price of Aurobindo Pharma Ltd is influenced by factors such as the company's financial performance, including earnings and revenue, as well as broader economic conditions and market trends. Furthermore, developments in the industry, regulatory changes, and geopolitical events can also impact the share price over time.

What are the key events that typically impact Aurobindo Pharma Ltd's share price history?

Key events that impact Aurobindo Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.

How do stock splits affect Aurobindo Pharma Ltd's share price history?

Stock splits reduce the nominal price of Aurobindo Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.

How do dividends impact the share price history of Aurobindo Pharma Ltd?

Dividends can influence Aurobindo Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.

How do corporate announcements affect Aurobindo Pharma Ltd’s share price history?

Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Aurobindo Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.

How can I use technical analysis to understand Aurobindo Pharma Ltd’s share price history?

To understand Aurobindo Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*